Cite
HARVARD Citation
Tosoian, J. et al. (2017). Prognostic utility of biopsy‐derived cell cycle progression score in patients with National Comprehensive Cancer Network low‐risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance. BJU international. pp. 808-814. [Online].